image
Healthcare - Medical - Healthcare Information Services - NYSE - US
$ 8.805
-2.06 %
$ 1.03 B
Market Cap
-10.87
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Mar, 3, 2025.

The intrinsic value of one EVH stock under the worst case scenario is HIDDEN Compared to the current market price of 8.8 USD, Evolent Health, Inc. is HIDDEN

This DCF valuation model was last updated on Mar, 3, 2025.

The intrinsic value of one EVH stock under the base case scenario is HIDDEN Compared to the current market price of 8.8 USD, Evolent Health, Inc. is HIDDEN

This DCF valuation model was last updated on Mar, 3, 2025.

The intrinsic value of one EVH stock under the best case scenario is HIDDEN Compared to the current market price of 8.8 USD, Evolent Health, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS
FINANCIALS
2.55 B REVENUE
30.09%
-40.5 M OPERATING INCOME
43.15%
-61.6 M NET INCOME
45.49%
18.8 M OPERATING CASH FLOW
-86.84%
-62.9 M INVESTING CASH FLOW
84.86%
0 FINANCING CASH FLOW
0.00%
647 M REVENUE
4.05%
-18.6 M OPERATING INCOME
-14.31%
-23.1 M NET INCOME
-1449.69%
18.7 M OPERATING CASH FLOW
-12.83%
-19.7 M INVESTING CASH FLOW
-45.70%
-9.01 M FINANCING CASH FLOW
91.29%
Balance Sheet Evolent Health, Inc.
image
Current Assets 684 M
Cash & Short-Term Investments 193 M
Receivables 447 M
Other Current Assets 44.1 M
Non-Current Assets 2 B
Long-Term Investments 4.9 M
PP&E 90.2 M
Other Non-Current Assets 1.9 B
Current Liabilities 674 M
Accounts Payable 48.2 M
Short-Term Debt 9.74 M
Other Current Liabilities 616 M
Non-Current Liabilities 938 M
Long-Term Debt 635 M
Other Non-Current Liabilities 303 M
EFFICIENCY
Earnings Waterfall Evolent Health, Inc.
image
Revenue 2.55 B
Cost Of Revenue 2.19 B
Gross Profit 367 M
Operating Expenses 408 M
Operating Income -40.5 M
Other Expenses 21.1 M
Net Income -61.6 M
RATIOS
14.38% GROSS MARGIN
14.38%
-1.58% OPERATING MARGIN
-1.58%
-3.66% NET MARGIN
-3.66%
0.00% ROE
0.00%
0.00% ROA
0.00%
0.00% ROIC
0.00%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Evolent Health, Inc.
image
Net Income -61.6 M
Depreciation & Amortization 123 M
Capital Expenditures -24.9 M
Stock-Based Compensation 39.7 M
Change in Working Capital 0
Others -79.5 M
Free Cash Flow -6.13 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Evolent Health, Inc.
image
Wall Street analysts predict an average 1-year price target for EVH of $30.3 , with forecasts ranging from a low of $14 to a high of $51 .
EVH Lowest Price Target Wall Street Target
14 USD 59.00%
EVH Average Price Target Wall Street Target
30.3 USD 243.81%
EVH Highest Price Target Wall Street Target
51 USD 479.22%
4. DIVIDEND ANALYSIS
5. COMPETITION
6. Ownership
Insider Ownership Evolent Health, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
9.63 M USD 5
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
6 months ago
Aug 22, 2024
Sell 501 K USD
McCarthy Daniel Joseph
PRESIDENT
- 16693
30 USD
6 months ago
Aug 22, 2024
Sell 231 K USD
McCarthy Daniel Joseph
PRESIDENT
- 7000
33 USD
6 months ago
Aug 23, 2024
Sell 207 K USD
McCarthy Daniel Joseph
PRESIDENT
- 6469
32 USD
6 months ago
Aug 23, 2024
Sell 132 K USD
McCarthy Daniel Joseph
PRESIDENT
- 4000
33 USD
6 months ago
Aug 22, 2024
Sell 808 K USD
Weinberg Jonathan
General Counsel
- 25253
32 USD
6 months ago
Aug 22, 2024
Sell 507 K USD
Weinberg Jonathan
General Counsel
- 16887
30 USD
6 months ago
Aug 22, 2024
Sell 5.64 M USD
Blackley Seth
Chief Executive Officer
- 187904
30 USD
6 months ago
Aug 22, 2024
Sell 1.34 M USD
Johnson John Paul
Chief Financial Officer
- 44693
30 USD
6 months ago
Aug 22, 2024
Sell 266 K USD
Rafferty Emily Ann
Chief Operating Officer
- 8861
30 USD
1 year ago
Dec 05, 2023
Sell 707 K USD
Blackley Seth
Chief Executive Officer
- 27484
25.74 USD
1 year ago
Dec 05, 2023
Sell 2.46 M USD
Blackley Seth
Chief Executive Officer
- 92616
26.61 USD
1 year ago
Dec 05, 2023
Sell 570 K USD
Blackley Seth
Chief Executive Officer
- 20900
27.25 USD
1 year ago
Nov 15, 2023
Sell 120 K USD
McCarthy Daniel Joseph
PRESIDENT
- 4000
30 USD
1 year ago
Nov 15, 2023
Sell 90 K USD
McCarthy Daniel Joseph
PRESIDENT
- 3000
30 USD
1 year ago
Aug 15, 2023
Sell 222 K USD
Rafferty Emily Ann
Chief Operating Officer
- 7900
28.05 USD
1 year ago
Jun 28, 2023
Sell 752 K USD
Blackley Seth
Chief Executive Officer
- 24542
30.65 USD
1 year ago
Jun 28, 2023
Sell 264 K USD
Blackley Seth
Chief Executive Officer
- 8469
31.15 USD
1 year ago
Jun 15, 2023
Sell 2.29 M USD
Blackley Seth
Chief Executive Officer
- 75931
30.2 USD
1 year ago
Jun 16, 2023
Sell 63.3 K USD
Blackley Seth
Chief Executive Officer
- 2098
30.16 USD
1 year ago
Jun 14, 2023
Sell 71 K USD
Scott Cheryl
Director
- 2365
30.01 USD
1 year ago
Jun 13, 2023
Sell 172 K USD
DUFFY MARY BRIDGET
Director
- 5564
30.97 USD
1 year ago
Jun 12, 2023
Sell 375 K USD
Holder Diane
Director
- 12000
31.26 USD
1 year ago
Jun 12, 2023
Sell 31.4 K USD
McCarthy Daniel Joseph
PRESIDENT
- 1000
31.44 USD
1 year ago
Jun 01, 2023
Sell 266 K USD
WILLIAMS FRANK J
Director
- 9091
29.27 USD
1 year ago
Jun 01, 2023
Sell 297 K USD
WILLIAMS FRANK J
Director
- 9969
29.75 USD
1 year ago
Jun 01, 2023
Sell 1.23 M USD
WILLIAMS FRANK J
Director
- 41914
29.26 USD
1 year ago
Jun 01, 2023
Sell 1.46 M USD
WILLIAMS FRANK J
Director
- 49026
29.74 USD
1 year ago
May 01, 2023
Sell 3.99 M USD
WILLIAMS FRANK J
Director
- 110000
36.29 USD
1 year ago
Apr 03, 2023
Sell 3.31 M USD
WILLIAMS FRANK J
Director
- 104126
31.8 USD
1 year ago
Apr 03, 2023
Sell 190 K USD
WILLIAMS FRANK J
Director
- 5874
32.37 USD
1 year ago
Mar 06, 2023
Sell 2.47 M USD
Blackley Seth
Chief Executive Officer
- 71916
34.4 USD
1 year ago
Mar 06, 2023
Sell 70.4 K USD
Blackley Seth
Chief Executive Officer
- 2012
35.01 USD
1 year ago
Mar 07, 2023
Sell 3.29 M USD
Blackley Seth
Chief Executive Officer
- 95055
34.62 USD
1 year ago
Mar 06, 2023
Sell 3.02 M USD
WILLIAMS FRANK J
Director
- 87901
34.4 USD
1 year ago
Mar 06, 2023
Sell 85.9 K USD
WILLIAMS FRANK J
Director
- 2455
35.01 USD
1 year ago
Mar 07, 2023
Sell 4.03 M USD
WILLIAMS FRANK J
Director
- 116311
34.62 USD
2 years ago
Mar 01, 2023
Sell 317 K USD
WILLIAMS FRANK J
Director
- 9060
34.97 USD
2 years ago
Mar 01, 2023
Sell 3.53 M USD
WILLIAMS FRANK J
Director
- 100940
34.98 USD
2 years ago
Feb 01, 2023
Sell 3.49 M USD
WILLIAMS FRANK J
Director
- 108500
32.15 USD
2 years ago
Feb 01, 2023
Sell 49 K USD
WILLIAMS FRANK J
Director
- 1500
32.66 USD
2 years ago
Jan 03, 2023
Sell 2.89 M USD
WILLIAMS FRANK J
Director
- 106708
27.12 USD
2 years ago
Jan 03, 2023
Sell 92.8 K USD
WILLIAMS FRANK J
Director
- 3292
28.18 USD
2 years ago
Dec 01, 2022
Sell 3.09 M USD
WILLIAMS FRANK J
Director
- 109100
28.29 USD
2 years ago
Dec 01, 2022
Sell 26.2 K USD
WILLIAMS FRANK J
Director
- 900
29.09 USD
2 years ago
Nov 21, 2022
Sell 2.01 M USD
Blackley Seth
Chief Executive Officer
- 75000
26.79 USD
2 years ago
Nov 01, 2022
Sell 1.1 M USD
WILLIAMS FRANK J
Director
- 38112
28.88 USD
2 years ago
Nov 01, 2022
Sell 1.69 M USD
WILLIAMS FRANK J
Director
- 57438
29.36 USD
2 years ago
Nov 01, 2022
Sell 417 K USD
WILLIAMS FRANK J
Director
- 13773
30.26 USD
2 years ago
Nov 01, 2022
Sell 21.5 K USD
WILLIAMS FRANK J
Director
- 677
31.81 USD
2 years ago
Aug 31, 2022
Sell 114 K USD
Scott Cheryl
director:
- 3100
36.76 USD
2 years ago
Aug 23, 2022
Sell 1.86 M USD
WILLIAMS FRANK J
director:
- 50000
37.21 USD
2 years ago
Aug 23, 2022
Sell 5.36 M USD
WILLIAMS FRANK J
Director
- 150000
35.75 USD
2 years ago
Aug 16, 2022
Sell 248 K USD
DUFFY MARY BRIDGET
director:
- 7500
33.13 USD
2 years ago
Aug 17, 2022
Sell 629 K USD
Johnson John Paul
Chief Financial Officer
- 18434
34.11 USD
2 years ago
Aug 12, 2022
Sell 501 K USD
Weinberg Jonathan
General Counsel
- 14335
34.96 USD
3 years ago
Mar 03, 2022
Sell 52.4 K USD
Tutewohl Steve
Chief Operating Officer
- 1918
27.3 USD
3 years ago
Mar 01, 2022
Sell 148 K USD
Tutewohl Steve
Chief Operating Officer
- 5388
27.41 USD
3 years ago
Feb 17, 2022
Sell 237 K USD
WILLIAMS FRANK J
Director
- 10000
23.7 USD
3 years ago
Feb 17, 2022
Sell 237 K USD
WILLIAMS FRANK J
Director
- 10000
23.7 USD
3 years ago
Feb 03, 2022
Sell 39 K USD
Tutewohl Steve
Chief Operating Officer
- 1707
22.85 USD
3 years ago
Feb 01, 2022
Sell 148 K USD
Tutewohl Steve
Chief Operating Officer
- 6313
23.47 USD
3 years ago
Jan 18, 2022
Sell 243 K USD
WILLIAMS FRANK J
Director
- 10000
24.31 USD
3 years ago
Jan 18, 2022
Sell 243 K USD
WILLIAMS FRANK J
Director
- 10000
24.3 USD
3 years ago
Dec 17, 2021
Sell 266 K USD
WILLIAMS FRANK J
Executive Chairman
- 10000
26.64 USD
3 years ago
Dec 17, 2021
Sell 266 K USD
WILLIAMS FRANK J
Executive Chairman
- 10000
26.65 USD
3 years ago
Nov 17, 2021
Sell 278 K USD
WILLIAMS FRANK J
Executive Chairman
- 10000
27.81 USD
3 years ago
Nov 17, 2021
Sell 278 K USD
WILLIAMS FRANK J
Executive Chairman
- 10000
27.81 USD
3 years ago
Oct 18, 2021
Sell 304 K USD
WILLIAMS FRANK J
Executive Chairman
- 10000
30.35 USD
3 years ago
Oct 18, 2021
Sell 304 K USD
WILLIAMS FRANK J
Executive Chairman
- 10000
30.35 USD
3 years ago
Oct 15, 2021
Sell 4.48 M USD
Blackley Seth
Chief Executive Officer
- 150000
29.86 USD
3 years ago
Sep 29, 2021
Sell 790 K USD
Weinberg Jonathan
General Counsel
- 28000
28.22 USD
3 years ago
Sep 17, 2021
Sell 263 K USD
WILLIAMS FRANK J
Executive Chairman
- 10000
26.27 USD
3 years ago
Sep 17, 2021
Sell 263 K USD
WILLIAMS FRANK J
Executive Chairman
- 10000
26.27 USD
3 years ago
Sep 01, 2021
Sell 340 K USD
Tutewohl Steve
Chief Operating Officer
- 13553
25.05 USD
3 years ago
Aug 17, 2021
Sell 229 K USD
WILLIAMS FRANK J
Executive Chairman
- 10000
22.88 USD
3 years ago
Aug 17, 2021
Sell 229 K USD
WILLIAMS FRANK J
Executive Chairman
- 10000
22.88 USD
3 years ago
Aug 10, 2021
Sell 198 K USD
Weinberg Jonathan
General Counsel
- 8254
24.01 USD
3 years ago
Aug 06, 2021
Sell 45.8 K USD
Weinberg Jonathan
General Counsel
- 1900
24.11 USD
3 years ago
Aug 09, 2021
Sell 367 K USD
Weinberg Jonathan
General Counsel
- 15277
24.05 USD
3 years ago
Aug 03, 2021
Sell 318 K USD
Tutewohl Steve
Chief Operating Officer
- 13801
23.02 USD
3 years ago
Aug 02, 2021
Sell 141 K USD
WILLIAMS FRANK J
Executive Chairman
- 6144
23.02 USD
3 years ago
Aug 03, 2021
Sell 596 K USD
WILLIAMS FRANK J
Executive Chairman
- 25871
23.02 USD
3 years ago
Aug 03, 2021
Sell 597 K USD
WILLIAMS FRANK J
Executive Chairman
- 25919
23.02 USD
3 years ago
Jul 30, 2021
Sell 43.7 K USD
WILLIAMS FRANK J
Executive Chairman
- 1901
23 USD
3 years ago
Jul 30, 2021
Sell 36.8 K USD
WILLIAMS FRANK J
Executive Chairman
- 1601
23 USD
3 years ago
Jul 19, 2021
Sell 216 K USD
WILLIAMS FRANK J
Executive Chairman
- 10000
21.6 USD
3 years ago
Jul 19, 2021
Sell 216 K USD
WILLIAMS FRANK J
Executive Chairman
- 10000
21.6 USD
3 years ago
Jul 09, 2021
Sell 82.4 K USD
WILLIAMS FRANK J
Executive Chairman
- 3584
23 USD
3 years ago
Jul 09, 2021
Sell 238 K USD
Tutewohl Steve
Chief Operating Officer
- 10576
22.52 USD
3 years ago
Jul 09, 2021
Sell 33.7 K USD
Tutewohl Steve
Chief Operating Officer
- 1465
23 USD
3 years ago
Jul 08, 2021
Sell 4.4 K USD
Tutewohl Steve
Chief Operating Officer
- 200
22 USD
3 years ago
Jul 01, 2021
Sell 197 K USD
Tutewohl Steve
Chief Operating Officer
- 9352
21.05 USD
3 years ago
Jun 17, 2021
Sell 197 K USD
WILLIAMS FRANK J
Executive Chairman
- 10000
19.7 USD
3 years ago
Jun 11, 2021
Sell 124 K USD
Scott Cheryl
Director
- 6405
19.39 USD
3 years ago
May 17, 2021
Sell 198 K USD
WILLIAMS FRANK J
Executive Chairman
- 10000
19.81 USD
3 years ago
May 17, 2021
Sell 196 K USD
WILLIAMS FRANK J
Executive Chairman
- 10000
19.65 USD
3 years ago
May 04, 2021
Sell 427 K USD
Weinberg Jonathan
General Counsel
- 20000
21.37 USD
3 years ago
May 03, 2021
Sell 214 K USD
Tutewohl Steve
Chief Operating Officer
- 9943
21.48 USD
3 years ago
May 03, 2021
Sell 201 K USD
Tutewohl Steve
Chief Operating Officer
- 9352
21.49 USD
4 years ago
Aug 05, 2020
Sell 130 K USD
Weinberg Jonathan
General Counsel
- 10000
13.01 USD
5 years ago
Dec 04, 2019
Bought 99.3 K USD
Blackley Seth
President
+ 14749
6.73 USD
5 years ago
Dec 03, 2019
Bought 228 K USD
WILLIAMS FRANK J
Chief Executive Officer
+ 35000
6.51 USD
5 years ago
Aug 15, 2019
Bought 50.7 K USD
SAMET KENNETH A
Director
+ 7200
7.04 USD
5 years ago
Mar 11, 2019
Bought 124 K USD
D'Amato Michael
Director
+ 10000
12.45 USD
5 years ago
Aug 09, 2019
Bought 105 K USD
D'Amato Michael
Director
+ 15000
7.03 USD
5 years ago
Mar 11, 2019
Sell 122 K USD
D'Amato Michael
Director
- 10000
12.25 USD
6 years ago
Sep 13, 2018
Sell 407 K USD
Weinberg Jonathan
General Counsel
- 15000
27.12 USD
6 years ago
Sep 13, 2018
Sell 1.92 M USD
Peterson Thomas III
Chief Operating Officer
- 70000
27.5 USD
6 years ago
Aug 30, 2018
Sell 750 K USD
Peterson Thomas III
Chief Operating Officer
- 30000
25 USD
6 years ago
Aug 30, 2018
Sell 38.3 K USD
Stone Lydia
Chief Accounting Officer
- 1532
25 USD
6 years ago
Aug 20, 2018
Sell 93.1 K USD
WILLIAMS FRANK J
- 3878
24 USD
6 years ago
Aug 16, 2018
Sell 719 K USD
WILLIAMS FRANK J
- 29953
24.02 USD
6 years ago
Aug 17, 2018
Sell 191 K USD
WILLIAMS FRANK J
- 7956
24 USD
6 years ago
Aug 14, 2018
Sell 852 K USD
WILLIAMS FRANK J
Chief Executive Officer
- 35470
24.02 USD
6 years ago
Aug 15, 2018
Sell 133 K USD
WILLIAMS FRANK J
Chief Executive Officer
- 5545
24 USD
6 years ago
Aug 01, 2018
Sell 200 K USD
Peterson Thomas III
Chief Executive Officer
- 10000
19.96 USD
6 years ago
Aug 01, 2018
Sell 193 K USD
WILLIAMS FRANK J
Chief Executive Officer
- 9653
19.97 USD
6 years ago
Jul 06, 2018
Sell 468 K USD
Blackley Seth
President
- 20610
22.72 USD
6 years ago
Jul 06, 2018
Sell 718 K USD
Blackley Seth
President
- 31554
22.74 USD
6 years ago
Jul 03, 2018
Sell 1.08 M USD
Blackley Seth
President
- 48930
22.16 USD
6 years ago
Jul 05, 2018
Sell 754 K USD
Blackley Seth
President
- 33467
22.52 USD
6 years ago
Jul 05, 2018
Sell 735 K USD
Blackley Seth
President
- 32643
22.51 USD
6 years ago
Jul 02, 2018
Sell 887 K USD
Blackley Seth
President
- 41824
21.21 USD
6 years ago
Jul 02, 2018
Sell 889 K USD
Blackley Seth
President
- 41873
21.22 USD
6 years ago
Jul 02, 2018
Sell 212 K USD
Peterson Thomas III
Chief Operating Officer
- 10000
21.21 USD
6 years ago
Jul 02, 2018
Sell 217 K USD
WILLIAMS FRANK J
Chief Executive Officer
- 10231
21.22 USD
6 years ago
Jun 21, 2018
Sell 1.14 M USD
WILLIAMS FRANK J
Chief Executive Officer
- 47314
24 USD
6 years ago
Jun 18, 2018
Sell 389 K USD
Blackley Seth
President
- 16674
23.33 USD
6 years ago
Jun 11, 2018
Sell 36.2 K USD
Scott Cheryl
Director
- 1600
22.63 USD
6 years ago
Jun 04, 2018
Sell 280 K USD
Blackley Seth
President
- 13781
20.34 USD
6 years ago
Jun 04, 2018
Sell 60.4 K USD
Blackley Seth
President
- 2885
20.95 USD
6 years ago
Jun 01, 2018
Sell 200 K USD
Peterson Thomas III
Chief Operating Officer
- 10000
20.04 USD
6 years ago
Jun 01, 2018
Sell 301 K USD
WILLIAMS FRANK J
Chief Executive Officer
- 15000
20.04 USD
6 years ago
Jun 01, 2018
Sell 55 M USD
UNITEDHEALTH GROUP INC
Director
- 2861065
19.23 USD
6 years ago
May 22, 2018
Sell 300 K USD
Weinberg Jonathan
General Counsel
- 15000
20.02 USD
6 years ago
May 21, 2018
Sell 323 K USD
Blackley Seth
President
- 16666
19.39 USD
6 years ago
May 14, 2018
Sell 189 K USD
Peterson Thomas III
Chief Operating Officer
- 10000
18.91 USD
6 years ago
May 14, 2018
Sell 285 K USD
WILLIAMS FRANK J
Chief Executive Officer
- 15000
19.02 USD
6 years ago
May 10, 2018
Sell 1.14 M USD
Blackley Seth
President
- 64398
17.63 USD
6 years ago
May 07, 2018
Sell 1.38 M USD
Blackley Seth
President
- 80472
17.09 USD
6 years ago
May 08, 2018
Sell 87.1 K USD
Blackley Seth
President
- 5124
17 USD
7 years ago
Mar 01, 2018
Sell 41.6 M USD
UNITEDHEALTH GROUP INC
Director
- 3040000
13.7 USD
7 years ago
Aug 03, 2017
Sell 387 K USD
WILLIAMS FRANK J
Chief Executive Officer
- 16300
23.73 USD
7 years ago
Aug 01, 2017
Sell 148 K USD
WIGGINTON STEVE
CEO, Valence Health
- 6000
24.64 USD
7 years ago
Jul 24, 2017
Sell 365 K USD
Peterson Thomas III
Chief Operating Officer
- 14033
26 USD
7 years ago
Jul 24, 2017
Sell 689 K USD
Peterson Thomas III
Chief Operating Officer
- 26507
26 USD
7 years ago
Jul 10, 2017
Sell 42.4 K USD
McGrane Nicholas
Chief Financial Officer
- 1667
25.42 USD
7 years ago
Jul 06, 2017
Sell 372 K USD
WILLIAMS FRANK J
Chief Executive Officer
- 15050
24.72 USD
7 years ago
Jul 06, 2017
Sell 31.6 K USD
WILLIAMS FRANK J
Chief Executive Officer
- 1250
25.27 USD
7 years ago
Jul 03, 2017
Sell 150 K USD
WIGGINTON STEVE
CEO, Valence Health
- 6000
25.07 USD
7 years ago
Jun 28, 2017
Sell 111 M USD
TPG Growth II Advisors, Inc.
10 percent owner
- 4279325
25.87 USD
7 years ago
Jun 15, 2017
Sell 378 K USD
Blackley Seth
President
- 15000
25.22 USD
7 years ago
Jun 12, 2017
Sell 38.4 K USD
McGrane Nicholas
Chief Financial Officer
- 1567
24.53 USD
7 years ago
Jun 12, 2017
Sell 2.54 K USD
McGrane Nicholas
Chief Financial Officer
- 100
25.4 USD
7 years ago
Jun 06, 2017
Sell 103 K USD
SAMET KENNETH A
Director
- 4000
25.75 USD
7 years ago
Jun 06, 2017
Sell 24.7 K USD
WIGGINTON STEVE
CEO, Valence Health
- 959
25.75 USD
7 years ago
Jun 06, 2017
Sell 12.7 K USD
McGrane Nicholas
Chief Financial Officer
- 495
25.75 USD
7 years ago
Jun 07, 2017
Sell 270 K USD
McGrane Nicholas
Chief Financial Officer
- 10000
27.01 USD
7 years ago
Jun 01, 2017
Sell 20.4 K USD
Stone Lydia
Principal Accounting Officer
- 887
22.95 USD
7 years ago
Jun 01, 2017
Sell 23 K USD
Stone Lydia
Principal Accounting Officer
- 1000
23.04 USD
7 years ago
Jun 01, 2017
Sell 66.5 K USD
Stone Lydia
Principal Accounting Officer
- 2908
22.87 USD
7 years ago
Jun 01, 2017
Sell 37.6 K USD
WIGGINTON STEVE
CEO, Valence Health
- 1600
23.51 USD
7 years ago
Jun 01, 2017
Sell 107 K USD
WIGGINTON STEVE
CEO, Valence Health
- 4400
24.36 USD
7 years ago
Jun 01, 2017
Sell 106 K USD
WILLIAMS FRANK J
Chief Executive Officer
- 4500
23.49 USD
7 years ago
Jun 01, 2017
Sell 287 K USD
WILLIAMS FRANK J
Chief Executive Officer
- 11800
24.36 USD
7 years ago
May 30, 2017
Sell 343 K USD
Blackley Seth
President
- 15000
22.86 USD
7 years ago
May 19, 2017
Sell 331 K USD
WIGGINTON STEVE
- 13640
24.3 USD
7 years ago
May 19, 2017
Sell 1.4 M USD
Peterson Thomas III
- 57433
24.3 USD
7 years ago
May 19, 2017
Sell 2.79 M USD
Blackley Seth
- 114865
24.3 USD
7 years ago
May 19, 2017
Sell 2.79 M USD
WILLIAMS FRANK J
- 114865
24.3 USD
7 years ago
May 19, 2017
Sell 1.15 M USD
McGrane Nicholas
- 47508
24.3 USD
7 years ago
May 19, 2017
Sell 419 K USD
Weinberg Jonathan
- 17230
24.3 USD
7 years ago
May 19, 2017
Sell 129 K USD
Scott Cheryl
Director
- 5477
23.51 USD
7 years ago
May 19, 2017
Sell 24.3 M USD
ADVISORY BOARD CO
10 percent owner
- 1000000
24.3 USD
7 years ago
May 19, 2017
Sell 74.9 M USD
TPG Growth II Advisors, Inc.
10 percent owner
- 3081760
24.3 USD
7 years ago
May 19, 2017
Sell 56.7 M USD
UPMC
10 percent owner
- 2333333
24.3 USD
7 years ago
May 15, 2017
Sell 519 K USD
Peterson Thomas III
Chief Operating Officer
- 20777
25 USD
7 years ago
May 15, 2017
Sell 519 K USD
Peterson Thomas III
Chief Operating Officer
- 20777
24.99 USD
7 years ago
May 15, 2017
Sell 519 K USD
Peterson Thomas III
Chief Operating Officer
- 20777
24.99 USD
7 years ago
May 15, 2017
Sell 519 K USD
Peterson Thomas III
Chief Operating Officer
- 20777
24.99 USD
7 years ago
May 15, 2017
Sell 375 K USD
Blackley Seth
President
- 15000
25 USD
7 years ago
May 12, 2017
Sell 233 K USD
Peterson Thomas III
Chief Operating Officer
- 9328
25 USD
7 years ago
May 12, 2017
Sell 428 K USD
Peterson Thomas III
Chief Operating Officer
- 17114
25 USD
7 years ago
May 10, 2017
Sell 157 K USD
Peterson Thomas III
Chief Operating Officer
- 6265
25 USD
7 years ago
May 10, 2017
Sell 308 K USD
Peterson Thomas III
Chief Operating Officer
- 12339
25 USD
7 years ago
May 10, 2017
Sell 40.5 K USD
McGrane Nicholas
Cheif Financial Officer
- 1667
24.28 USD
7 years ago
May 04, 2017
Sell 384 K USD
WILLIAMS FRANK J
Chief Executive Officer
- 16300
23.55 USD
7 years ago
May 03, 2017
Sell 358 K USD
Weinberg Jonathan
General Counsel
- 15000
23.85 USD
7 years ago
May 01, 2017
Sell 139 K USD
WIGGINTON STEVE
CEO, Valence Health
- 6000
23.1 USD
7 years ago
May 01, 2017
Sell 7.32 M USD
TPG Growth II Advisors, Inc.
10 percent owner
- 374812
19.53 USD
7 years ago
May 01, 2017
Sell 347 K USD
Blackley Seth
President
- 15000
23.11 USD
7 years ago
May 01, 2017
Sell 7.88 M USD
UPMC
10 percent owner
- 403644
19.53 USD
7 years ago
May 01, 2017
Sell 6.2 M USD
ADVISORY BOARD CO
10 percent owner
- 317712
19.53 USD
7 years ago
Apr 19, 2017
Sell 37.5 K USD
McGrane Nicholas
Chief Financial Officer
- 1667
22.52 USD
7 years ago
Apr 17, 2017
Sell 242 K USD
Blackley Seth
President
- 11342
21.35 USD
7 years ago
Apr 17, 2017
Sell 80 K USD
Blackley Seth
President
- 3658
21.88 USD
7 years ago
Apr 06, 2017
Sell 359 K USD
WILLIAMS FRANK J
Chief Executive Officer
- 16300
22.03 USD
7 years ago
Apr 03, 2017
Sell 122 K USD
WIGGINTON STEVE
CEO, Valence Health
- 5300
23.11 USD
7 years ago
Apr 03, 2017
Sell 16.4 K USD
WIGGINTON STEVE
CEO, Valence Health
- 700
23.41 USD
7 years ago
Mar 31, 2017
Sell 48.8 M USD
TPG Growth II Advisors, Inc.
10 percent owner
- 2498750
19.53 USD
7 years ago
Mar 31, 2017
Sell 52.6 M USD
UPMC
10 percent owner
- 2690961
19.53 USD
7 years ago
Mar 30, 2017
Sell 290 K USD
Blackley Seth
President
- 13716
21.14 USD
7 years ago
Mar 30, 2017
Sell 27.9 K USD
Blackley Seth
President
- 1284
21.76 USD
7 years ago
Mar 28, 2017
Sell 41.4 M USD
ADVISORY BOARD CO
10 percent owner
- 2118078
19.53 USD
7 years ago
Mar 24, 2017
Sell 113 K USD
McGrane Nicholas
Chief Financial Officer
- 5001
22.5 USD
7 years ago
Mar 24, 2017
Sell 45.7 K USD
McGrane Nicholas
Chief Financial Officer
- 2033
22.5 USD
7 years ago
Mar 15, 2017
Sell 215 K USD
Blackley Seth
President
- 10396
20.68 USD
7 years ago
Mar 15, 2017
Sell 98 K USD
Blackley Seth
President
- 4604
21.29 USD
8 years ago
Mar 03, 2017
Sell 20 K USD
WIGGINTON STEVE
CEO, Valence Health
- 988
20.2 USD
8 years ago
Mar 02, 2017
Sell 340 K USD
WILLIAMS FRANK J
Chief Executive Officer
- 16300
20.86 USD
8 years ago
Mar 01, 2017
Sell 162 K USD
Blackley Seth
President
- 8100
20.04 USD
8 years ago
Mar 01, 2017
Sell 57.7 K USD
Blackley Seth
President
- 2800
20.6 USD
8 years ago
Mar 01, 2017
Sell 86.6 K USD
Blackley Seth
President
- 4100
21.13 USD
8 years ago
Mar 01, 2017
Sell 121 K USD
WIGGINTON STEVE
CEO, Valence Health
- 6000
20.11 USD
8 years ago
Feb 15, 2017
Sell 121 K USD
WIGGINTON STEVE
CEO, Valence Health
- 6000
20.12 USD
8 years ago
Feb 15, 2017
Sell 121 K USD
WIGGINTON STEVE
CEO, Valence Health
- 6000
20.13 USD
8 years ago
Feb 15, 2017
Sell 329 K USD
WILLIAMS FRANK J
Chief Executive Officer
- 16300
20.16 USD
8 years ago
Feb 15, 2017
Sell 328 K USD
WILLIAMS FRANK J
Chief Executive Officer
- 16300
20.13 USD
8 years ago
Feb 15, 2017
Sell 287 K USD
Blackley Seth
President
- 15000
19.16 USD
8 years ago
Sep 22, 2016
Sell 8.07 M USD
TPG Growth II Advisors, Inc.
10 percent owner
- 374812
21.54 USD
8 years ago
Jan 30, 2017
Sell 264 K USD
Blackley Seth
President
- 15000
17.58 USD
8 years ago
Jan 12, 2017
Sell 255 K USD
Blackley Seth
President
- 15000
17.02 USD
8 years ago
Jan 17, 2017
Sell 284 K USD
Blackley Seth
President
- 15000
18.94 USD
8 years ago
Nov 14, 2016
Bought 172 K USD
D'Amato Michael
Director
+ 10000
17.18 USD
8 years ago
Sep 22, 2016
Sell 8.69 M USD
UPMC
10 percent owner
- 403644
21.54 USD
8 years ago
Sep 22, 2016
Sell 7.15 M USD
ADVISORY BOARD CO
10 percent owner
- 317712
22.5 USD
8 years ago
Sep 14, 2016
Sell 49.2 M USD
TPG Growth II Advisors, Inc.
10 percent owner
- 2284571
21.54 USD
8 years ago
Sep 14, 2016
Sell 53 M USD
UPMC
10 percent owner
- 2460307
21.54 USD
8 years ago
Sep 14, 2016
Sell 986 K USD
WIGGINTON STEVE
- 45760
21.54 USD
8 years ago
Sep 14, 2016
Sell 223 K USD
Weinberg Jonathan
- 10339
21.54 USD
8 years ago
Sep 14, 2016
Sell 396 K USD
Thornton Dave
- 18393
21.54 USD
8 years ago
Sep 14, 2016
Sell 1.19 M USD
Pomeroy Chad
- 55180
21.54 USD
8 years ago
Sep 14, 2016
Sell 1.57 M USD
Peterson Thomas III
- 72827
21.54 USD
8 years ago
Sep 14, 2016
Sell 457 K USD
McGrane Nicholas
- 21205
21.54 USD
8 years ago
Sep 14, 2016
Sell 3.61 M USD
Blackley Seth
- 167672
21.54 USD
8 years ago
Sep 14, 2016
Sell 5.42 M USD
WILLIAMS FRANK J
- 251481
21.54 USD
8 years ago
Sep 14, 2016
Sell 43.6 M USD
ADVISORY BOARD CO
10 percent owner
- 1936529
22.5 USD
8 years ago
Aug 15, 2016
Sell 12.8 K USD
Stone Lydia
- 500
25.62 USD
8 years ago
Aug 15, 2016
Sell 12.8 K USD
Stone Lydia
- 500
25.7 USD
9 years ago
Jun 10, 2015
Bought 34 K USD
Piefer Gary
Chief Medical Officer
+ 2000
17 USD
7. News
Evolent Health, Inc. (EVH) Q4 2024 Earnings Call Transcript Evolent Health, Inc. (NYSE:EVH ) Q4 2024 Earnings Conference Call February 20, 2025 5:00 PM ET Company Participants Seth Frank - Vice President, Investor Relations Seth Blackley - Chief Executive Officer John Johnson - Chief Financial Officer Conference Call Participants Matthew Gillmor - KeyBanc Charles Rhyee - TD Cowen Andrea Alfonso - UBS Jailendra Singh - Truist Securities Ryan Daniels - William Blair Jeff Garro – Stephens Anne Samuel - J.P. Morgan Richard Close - Canaccord Genuity Jessica Tassan - Piper Sandler David Larsen - BTIG Daniel Grosslight – Citi Matthew Shea - Needham Operator Welcome to the Evolent Earnings Conference Call for the Fourth Quarter and Year End December 31, 2024. seekingalpha.com - 1 week ago
Evolent Health (EVH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates The headline numbers for Evolent Health (EVH) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. zacks.com - 1 week ago
Evolent Health (EVH) Reports Q4 Loss, Lags Revenue Estimates Evolent Health (EVH) came out with a quarterly loss of $0.02 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.23 per share a year ago. zacks.com - 1 week ago
Evolent Announces Fourth Quarter and Full Year 2024 Results Revenue of $646.5 million for the three months ended December 31, 2024 and $2,554.7 million for the year ended December 31, 2024, representing 16.3% and 30.1% growth over 2023, respectively. Net loss attributable to common shareholders of Evolent Health, Inc. of $30.6 million for three months ended December 31, 2024 and $93.5 million for the year ended December 31, 2024, resulting in a net loss margin of (4.7)% and (3.7)%, respectively. prnewswire.com - 1 week ago
Evolent Health (EVH) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures Beyond analysts' top -and-bottom-line estimates for Evolent Health (EVH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024. zacks.com - 2 weeks ago
Earnings Preview: Evolent Health (EVH) Q4 Earnings Expected to Decline Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 2 weeks ago
Evolent Health Announces Changes to Board of Directors Richard " Rick "  Jelinek to Be Named Chair of the Board at 2025 Annual Meeting Company Continues Board Refreshment Efforts with Brendan Springstubb ' s Appointment as New Independent Director WASHINGTON , Feb. 4, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a company focused on achieving better health outcomes for people with complex conditions, today announced changes to its Board of Directors as part of the Company's ongoing commitment to strong corporate governance and to collaboration with shareholders. Rick Jelinek, who joined the Evolent Board as an independent director in 2023, will be named Chair of the Board at the 2025 Annual Meeting, succeeding Cheryl Scott. prnewswire.com - 3 weeks ago
New Strong Sell Stocks for January 30th DEC, ERO and EVH have been added to the Zacks Rank #5 (Strong Sell) List on January 30, 2024. zacks.com - 1 month ago
Evolent To Release Fourth Quarter 2024 Financial Results on Thursday, February 20, 2025 Company to Participate in Upcoming Conferences WASHINGTON , Jan. 27, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its fourth quarter 2024 financial results on Thursday, February 20, 2025, after market close, with a conference call to follow at 5 p.m. ET. Shareholders and interested participants may listen to a live broadcast of the conference call found on Evolent's investor relations website, https://ir.evolent.com. prnewswire.com - 1 month ago
Evolent dips after Truist warns guidance may be 'significantly' below consensus Truist analyst Jailendra Singh caught up with Evolent Health post its presentation at an investor healthcare conference and also noted that the company released an 8-K earlier in the week outlining some preliminary views on 2025. Evolent is encouraging investors to use Q4 EBITDA run-rate as the baseline for 2025 and the firm now sees the company's 2025 guidance range coming in "significantly below consensus," the analyst tells investors. Using about $25M of Q4 EBITDA as a baseline, the firm infers that Evolent is suggesting a potential initial FY25 EBITDA range of $140M-$170M, said the analyst, who has a Buy rating and $20 price target on the shares. In Wednesday trading, Evolent shares slid 10% to $10.02. https://thefly.com - 1 month ago
Evolent announces Dr. Von Nguyen as incoming Chief Medical Officer, effective January 1 Longtime CMO Dr. Andrew Hertler to serve as senior advisor and CMO emeritus. WASHINGTON , Dec. 18, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, announced the appointment of Dr. Von Nguyen as Chief Medical Officer, effective January 1, 2025. prnewswire.com - 2 months ago
New Strong Sell Stocks for December 12th ASH, BIDU and EVH have been added to the Zacks Rank #5 (Strong Sell) List on December 12, 2024. zacks.com - 2 months ago
8. Profile Summary

Evolent Health, Inc. EVH

image
COUNTRY US
INDUSTRY Medical - Healthcare Information Services
MARKET CAP $ 1.03 B
Dividend Yield 0.00%
Description Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.
Contact 800 North Glebe Road, Arlington, VA, 22203 https://www.evolenthealth.com
IPO Date June 5, 2015
Employees 4700
Officers Mr. Aammaad Shams Chief Accounting Officer Mr. Robert Cruz Chief Technology Officer Ms. Jessica White Chief Information Officer Mr. John Paul Johnson Chief Financial Officer Ms. Emily Rafferty Chief Operating Officer Ms. Katie DiPerna Cook Chief People Officer Mr. Dan McCarthy President Mr. Seth Barrie Blackley Co-Founder, Chief Executive Officer & Director Mr. Jonathan David Weinberg J.D. Chief Legal Officer, General Counsel & Secretary Mr. Seth R. Frank Vice President of Investor Relations